Trial Profile
Additive renoprotective effects of aliskiren in type 2 diabetic patients with albuminuria receiving telmisartan + amlodipine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2012
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Amlodipine; Telmisartan
- Indications Diabetic nephropathies; Hypertension
- Focus Pharmacodynamics
- 11 Sep 2012 New trial record